UPDATE : Friday, May 17, 2019
ImmuneOncia ends P1 clinical trials for solid cancer treatment
ImmuneOncia Therapeutics, a subsidiary of Yuhan Corp., said Tuesday that it...
by Lee Han-soo  |  2019-03-12 17:46
Drugmakers to name new CEOs, enhance ownership
The pharmaceutical industry is expected to witness significant changes in m...
by Jeong Sae-im  |  2019-03-12 16:17
Regulator OKs Humedix’s osteoarthritis treatment
Humedix said Monday that it has received sales approval for Humia, an osteo...
by Lee Han-soo  |  2019-03-12 13:55
HanAll starts P3 clinical trials for dry eye treatment in US
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo  |  2019-03-12 10:41
Kolon gets FDA nod for testing gene therapy for neuropathic pain
Kolon Life Science said Monday it obtained the U.S. Food and Drug Administr...
by Jeong Sae-im  |  2019-03-11 17:01
LSK Global PS sets up subsidiary
LSK Global PS said Monday that it has established a subsidiary called LSK N...
by Lee Han-soo  |  2019-03-11 15:14
LG Chem to develop sextuple influenza vaccine
LG Science Park in Gayang-dong, Seoul. LG Chem said Monday that it has re...
by Lee Han-soo  |  2019-03-11 14:31
Jeil releases P3 clinical trial results for anti-hypertension treatment
Jeil Pharmaceutical said Monday that it has published the phase 3 clinical ...
by Lee Han-soo  |  2019-03-11 14:03
Daewoong’s pulmonary fibrosis treatment wins government support
Daewoong Pharmaceutical said Friday that the Korea Drug Development Fund (K...
by Lee Han-soo  |  2019-03-08 16:57
Gilead, Yuhan to co-promote Biktarvy
Yuhan Corp. said Friday that it has signed an agreement with Gilead Science...
by Lee Han-soo  |  2019-03-08 15:32
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy
Roche Korea said Friday that its combination therapy -- Tecentriq and Alece...
by Lee Han-soo  |  2019-03-08 14:38
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that the Minist...
by Lee Han-soo  |  2019-03-07 16:22
Daewoong marks record-high sales in 2018
Daewoong Pharmaceutical said Wednesday that it recorded sales of 943.5 bill...
by Lee Han-soo  |  2019-03-07 16:01
When will NOAC reversal agents be available in Korea?
Several drugs that reverse the blood thinning effect of non-vitamin K oral ...
by Kim Yun-mi  |  2019-03-07 15:52
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon  |  2019-03-07 15:10
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo  |  2019-03-07 14:25
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im  |  2019-03-07 11:54
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate
Genexine said Monday that I-Mab Biopharma, a Chinese bio-firm, has administ...
by Lee Han-soo  |  2019-03-06 14:27
Binex, Chongqing Zein to establish joint company
Binex said Wednesday that it has signed an agreement to establish a joint-v...
by Lee Han-soo  |  2019-03-06 13:41
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin
Medytox continued Tuesday to pressure Daewoong Pharmaceuticals to clarify s...
by Lee Han-soo  |  2019-03-05 16:22
Back to Top